Missed pills: frequency, reasons, consequences and solutions
- PMID: 28277799
- DOI: 10.1080/13625187.2017.1295437
Missed pills: frequency, reasons, consequences and solutions
Abstract
Objectives: Oral hormonal contraception is an effective contraceptive method as long as regular daily intake is maintained. However, a daily routine is a constraint for many women and can lead to missed pills, pill discontinuation and/or unintended pregnancy. This article describes the frequency of inconsistent use, the consequences, the risk factors and the possible solutions.
Methods: The article comprises a narrative review of the literature.
Results: Forgetting one to three pills per cycle is a frequent problem among 15-51% of users, generally adolescents. The reasons for this are age, inability to establish a routine, pill unavailability, side effects, loss of motivation and lack of involvement in the initial decision to use oral contraceptives. The consequences are 'escape ovulations' and, possibly, unintended pregnancy. Solutions are either to use a long-acting method or, for women who prefer to take oral contraceptives, use a continuous or long-cycle regimen to reduce the risks of follicular development and thus the likelihood of ovulation and unintended pregnancy. A progestogen with a long half-life can increase ovarian suppression.
Conclusions: For women deciding to use oral contraceptives, a shortened or eliminated hormone-free interval and a progestogen with a long half-life may be an option to reduce the negative consequences of missed oral contraceptive pills.
Keywords: Compliance; efficacy; half-life; hormone-free interval; missed pill; nomegestrol acetate; non-compliance; progestogen; regimen.
Similar articles
-
Missed hormonal contraceptives: new recommendations.J Obstet Gynaecol Can. 2008 Nov;30(11):1050-1062. doi: 10.1016/S1701-2163(16)33001-8. J Obstet Gynaecol Can. 2008. PMID: 19126288 English, French.
-
Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.Am J Obstet Gynecol. 2017 Feb;216(2):101-109. doi: 10.1016/j.ajog.2016.08.033. Epub 2016 Sep 20. Am J Obstet Gynecol. 2017. PMID: 27662799 Free PMC article. Clinical Trial.
-
Depo Provera. Position paper on clinical use, effectiveness and side effects.Br J Fam Plann. 1999 Jul;25(2):69-76. Br J Fam Plann. 1999. PMID: 10454658 Review.
-
Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake.Contraception. 2016 Apr;93(4):303-309. doi: 10.1016/j.contraception.2015.12.007. Epub 2015 Dec 17. Contraception. 2016. PMID: 26708301 Clinical Trial.
-
Contraception in the adolescent patient.Prim Care. 1995 Mar;22(1):145-59. Prim Care. 1995. PMID: 7777635 Review.
Cited by
-
Contraception values and preferences of people living with HIV: A systematic review.Contraception. 2022 Jul;111:48-60. doi: 10.1016/j.contraception.2021.10.014. Epub 2021 Nov 5. Contraception. 2022. PMID: 34748747 Free PMC article.
-
Condom Use With Long-Acting Reversible Contraception vs Non-Long-Acting Reversible Contraception Hormonal Methods Among Postpartum Adolescents.JAMA Pediatr. 2019 Jul 1;173(7):663-670. doi: 10.1001/jamapediatrics.2019.1136. JAMA Pediatr. 2019. PMID: 31107513 Free PMC article.
-
A review of the pharmacology, clinical outcomes, and real-world effectiveness, safety, and non-contraceptive effects of NOMAC/E2.Eur J Obstet Gynecol Reprod Biol X. 2024 Jan 22;21:100283. doi: 10.1016/j.eurox.2024.100283. eCollection 2024 Mar. Eur J Obstet Gynecol Reprod Biol X. 2024. PMID: 38318398 Free PMC article. Review.
-
HIV PrEP is more than ART-lite: Longitudinal study of real-world PrEP services data identifies missing measures meaningful to HIV prevention programming.J Int AIDS Soc. 2021 Oct;24(10):e25827. doi: 10.1002/jia2.25827. J Int AIDS Soc. 2021. PMID: 34648678 Free PMC article.
-
Comparative effectiveness and safety of different progestins in combined oral contraceptives: a systematic review and network meta-analysis of randomized controlled trials.Arch Gynecol Obstet. 2025 Aug;312(2):351-362. doi: 10.1007/s00404-025-08050-2. Epub 2025 May 20. Arch Gynecol Obstet. 2025. PMID: 40392265 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical